{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:09:24Z","timestamp":1788739764994,"version":"build-2803163510"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Education in Saudi Arabia","award":["grant number 886"],"award-info":[{"award-number":["grant number 886"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-57604-0","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T02:46:40Z","timestamp":1781750800000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multitargeted comparative evaluation suggests 2-Aoeobenoxmide shows favourable in silico binding compared to Tucatinib against ER\u03b1, HER2, AKT1, EGFR, and PIK3CA in breast cancer"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8237-9079","authenticated-orcid":false,"given":"Mohammed H.","family":"Al-Qahtani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Alam","family":"Jafri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mourad","family":"Assidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelbaset","family":"Buhmeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Natesan","family":"Pushparaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha Khalid","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nofe Ateq","family":"Alganmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"7","key":"57604_CR1","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2025","unstructured":"Filho, A. M. et al. The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. Int. J. Cancer. 156(7), 1336\u201346 (2025).","journal-title":"Int. J. Cancer."},{"key":"57604_CR2","doi-asserted-by":"crossref","unstructured":"Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siege,l R. L., Soerjomataram, I. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A cancer journal for clinicians. 74(3):229-63 (2024).","DOI":"10.3322\/caac.21834"},{"issue":"1","key":"57604_CR3","doi-asserted-by":"publisher","first-page":"16545","DOI":"10.1038\/s41598-023-43789-1","volume":"13","author":"A Sahu","year":"2023","unstructured":"Sahu, A. et al. In-silico and in-vitro study reveals Ziprasidone as a potential aromatase inhibitor against breast carcinoma. Sci. Rep. 13(1), 16545 (2023).","journal-title":"Sci. Rep."},{"issue":"11","key":"57604_CR4","doi-asserted-by":"publisher","first-page":"5998","DOI":"10.1073\/pnas.95.11.5998","volume":"95","author":"DM Tanenbaum","year":"1998","unstructured":"Tanenbaum, D. M., Wang, Y., Williams, S. P. & Sigler, P. B. Crystallographic comparison of the estrogen and progesterone receptor\u2019s ligand binding domains. Proc. Natl Acad. Sci. 95(11), 5998\u20136003 (1998).","journal-title":"Proc. Natl Acad. Sci."},{"key":"57604_CR5","first-page":"721","volume":"2","author":"J Wang","year":"2023","unstructured":"Wang, J. & Wu, S.-G. Breast cancer: an overview of current therapeutic strategies, challenge, and perspectives. Breast Cancer: Targets Therapy. 2, 721\u201330 (2023).","journal-title":"Breast Cancer: Targets Therapy."},{"issue":"1","key":"57604_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/medsci8010018","volume":"8","author":"U Testa","year":"2020","unstructured":"Testa, U., Castelli, G. & Pelosi, E. Breast cancer: A molecularly heterogenous disease needing subtype-specific treatments. Med. Sci. 8(1), 18 (2020).","journal-title":"Med. Sci."},{"issue":"10","key":"57604_CR7","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s40265-020-01340-w","volume":"80","author":"A Lee","year":"2020","unstructured":"Lee, A. Tucatinib: First approval. Drugs. 80(10), 1033\u20138 (2020).","journal-title":"Drugs."},{"issue":"7","key":"57604_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1056\/NEJMoa1914609","volume":"382","author":"RK Murthy","year":"2020","unstructured":"Murthy, R. K. et al. Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer. New England J. Med. 382(7), 597\u2013609 (2020).","journal-title":"New England J. Med."},{"issue":"6","key":"57604_CR9","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.molonc.2014.06.005","volume":"8","author":"RA Burrell","year":"2014","unstructured":"Burrell, R. A. & Swanton, C. Tumour heterogeneity and the evolution of polyclonal drug resistance. Mol. Oncol.. 8(6), 1095\u2013111 (2014).","journal-title":"Mol. Oncol.."},{"key":"57604_CR10","doi-asserted-by":"publisher","first-page":"142343","DOI":"10.1016\/j.ijbiomac.2025.142343","volume":"5","author":"S Ahmad","year":"2025","unstructured":"Ahmad, S., Kumar, N., Gautam, H. K. & Raza, K. Probing the multitargeted potency of Theodrenaline and its comparative evaluation with Crizotinib against transferase, hydrolase, signalling, and apoptosis-related proteins to overcome lung cancer drug resistance. Int. J. Biol. Macromol. 5, 142343 (2025).","journal-title":"Int. J. Biol. Macromol."},{"key":"57604_CR11","doi-asserted-by":"crossref","unstructured":"Rexer BN, Arteaga CL. Intrinsic and acquired resistance to HER2-targeted therapies in HER2 gene-amplified breast cancer: mechanisms and clinical implications. Critical Reviews\u2122 in Oncogenesis. 17(1) (2012).","DOI":"10.1615\/CritRevOncog.v17.i1.20"},{"issue":"6","key":"57604_CR12","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3390\/cancers13061380","volume":"13","author":"Y Shlyakhtina","year":"2021","unstructured":"Shlyakhtina, Y., Moran, K. L. & Portal, M. M. Genetic and non-genetic mechanisms underlying cancer evolution. Cancers. 13(6), 1380 (2021).","journal-title":"Cancers."},{"issue":"19","key":"57604_CR13","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.3390\/cancers13194969","volume":"13","author":"S Beyes","year":"2021","unstructured":"Beyes, S., Bediaga, N. G. & Zippo, A. An epigenetic perspective on intra-tumour heterogeneity: Novel insights and new challenges from multiple fields. Cancers. 13(19), 4969 (2021).","journal-title":"Cancers."},{"key":"57604_CR14","doi-asserted-by":"crossref","unstructured":"Ahmad, S., Aslam, D., Ansari, A., Bhat, A. M., Raza, K. Deep learning in computer-aided drug design: A case study. Deep Learning Applications in Translational Bioinformatics: Elsevier; p. 191-210 (2024).","DOI":"10.1016\/B978-0-443-22299-3.00012-8"},{"key":"57604_CR15","doi-asserted-by":"publisher","first-page":"133872","DOI":"10.1016\/j.ijbiomac.2024.133872","volume":"276","author":"S Ahmad","year":"2024","unstructured":"Ahmad, S., Bano, N., Khanna, K., Gupta, D. & Raza, K. Reporting multitargeted potency of Tiaprofenic acid against lung cancer: Molecular fingerprinting, MD simulation, and MTT-based cell viability assay studies. Int. J. Biol. Macromol. 276, 133872 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"57604_CR16","doi-asserted-by":"crossref","unstructured":"Ahmad, S., Bano, N., Qazi, S., Yadav, M. K., Ahmad, N., Raza, K. Multitargeted molecular dynamic understanding of butoxypheser against SARS-CoV-2: An in silico study. Natural Product Communications. 17(7):1934578X221115499. (2022).","DOI":"10.1177\/1934578X221115499"},{"issue":"21","key":"57604_CR17","doi-asserted-by":"publisher","first-page":"18756","DOI":"10.1074\/jbc.M110.206193","volume":"286","author":"K Aertgeerts","year":"2011","unstructured":"Aertgeerts, K. et al. Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein. J. Biol. Chem. 286(21), 18756\u201365 (2011).","journal-title":"J. Biol. Chem."},{"issue":"11","key":"57604_CR18","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1021\/jm300276x","volume":"55","author":"MA Ashwell","year":"2012","unstructured":"Ashwell, M. A. et al. Discovery and optimization of a series of 3-(3-Phenyl-3 H-imidazo [4, 5-b] pyridin-2-yl) pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitors. J. Med. Chem. 55(11), 5291\u2013310 (2012).","journal-title":"J. Med. Chem."},{"issue":"2","key":"57604_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.str.2012.11.014","volume":"21","author":"KS Gajiwala","year":"2013","unstructured":"Gajiwala, K. S. et al. Insights into the aberrant activity of mutant EGFR kinase domain and drug recognition. Structure. 21(2), 209\u201319 (2013).","journal-title":"Structure."},{"issue":"14","key":"57604_CR20","doi-asserted-by":"publisher","first-page":"6326","DOI":"10.1021\/jacs.1c13568","volume":"144","author":"C Borsari","year":"2022","unstructured":"Borsari, C. et al. Covalent proximity scanning of a distal cysteine to target PI3K\u03b1. J. Am. Chem. Soc. 144(14), 6326\u201342 (2022).","journal-title":"J. Am. Chem. Soc."},{"issue":"1\u20133","key":"57604_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Del. Rev. 23(1\u20133), 3\u201325 (1997).","journal-title":"Adv. Drug Del. Rev."},{"key":"57604_CR22","doi-asserted-by":"crossref","unstructured":"Ahmad, S., Raza, K. Identification of 5-nitroindazole as a multitargeted inhibitor for CDK and transferase kinase in lung cancer: a multisampling algorithm-based structural study. Molecular Diversity. 1-14 (2023).","DOI":"10.1007\/s11030-023-10648-0"},{"key":"57604_CR23","doi-asserted-by":"crossref","unstructured":"Ahmad, S., Kishan, A., Chitkara, P., Asiri, S.A., Eswaran, M., Mehta, S. et al. Natural Product-Based Drug Designing for Treatment of Human Parasitic Diseases. Natural Product Based Drug Discovery Against Human Parasites: Opportunities and Challenges: Springer; p. 37-59 (2023).","DOI":"10.1007\/978-981-19-9605-4_3"},{"issue":"12","key":"57604_CR24","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber, D. F. et al. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem.. 45(12), 2615\u201323 (2002).","journal-title":"J. Med. Chem.."},{"issue":"9","key":"57604_CR25","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1080\/07391102.2022.2060308","volume":"41","author":"S Ahmad","year":"2023","unstructured":"Ahmad, S. et al. Reporting dinaciclib and theodrenaline as a multitargeted inhibitor against SARS-CoV-2: An in-silico study. J. Biomol. Struct. Dyn. 41(9), 4013\u201323 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"57604_CR26","unstructured":"Ahmad, S., Raza, K. An Extensive Review on Lung Cancer Therapeutics Using Machine Learning Techniques: State-of-the-art and Perspectives. Journal of Drug Targeting. (just-accepted):1-15 (2024)."},{"issue":"4","key":"57604_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski, C. A. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discov. Today: Technol. 1(4), 337\u201341 (2004).","journal-title":"Drug Discov. Today: Technol."},{"key":"57604_CR28","unstructured":"Maestro, S. Maestro. Schr\u00f6dinger, LLC, New York, NY. (2024)."},{"issue":"5","key":"57604_CR29","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1080\/07391102.2023.2209673","volume":"42","author":"S Ahmad","year":"2024","unstructured":"Ahmad, S., Singh, V., Gautam, H. K. & Raza, K. Multisampling-based docking reveals Imidazolidinyl urea as a multitargeted inhibitor for lung cancer: an optimisation followed multi-simulation and in-vitro study. J. Biomol. Struct. Dyn. 42(5), 2494\u2013511 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"13","key":"57604_CR30","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/jcc.10306","volume":"24","author":"G Wu","year":"2003","unstructured":"Wu, G., Robertson, D. H., Brooks, C. L. III. & Vieth, M. Detailed analysis of grid-based molecular docking: A case study of CDOCKER\u2014A CHARMm-based MD docking algorithm. J. Comput. Chem. 24(13), 1549\u201362 (2003).","journal-title":"J. Comput. Chem."},{"key":"57604_CR31","doi-asserted-by":"crossref","unstructured":"Ahmad, S., Sayeed, S., Bano, N., Sheikh, K., Raza, K. In-silico analysis reveals Quinic acid as a multitargeted inhibitor against cervical cancer. Journal of Biomolecular Structure and Dynamics. 1-17 (2022).","DOI":"10.1080\/07391102.2022.2146202"},{"key":"57604_CR32","doi-asserted-by":"crossref","unstructured":"Ahmad, S., Singh, A. P, Bano, N., Raza, K., Singh, J., Medigeshi GR, et al. Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis. International Journal of Biological Macromolecules. 132332 (2024).","DOI":"10.1016\/j.ijbiomac.2024.132332"},{"issue":"12","key":"57604_CR33","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","volume":"60","author":"JJ Irwin","year":"2020","unstructured":"Irwin, J. J. et al. ZINC20\u2014a free ultralarge-scale chemical database for ligand discovery. J. Chem. Inf. Model. 60(12), 6065\u201373 (2020).","journal-title":"J. Chem. Inf. Model."},{"key":"57604_CR34","unstructured":"Release, S. LigPrep, Schr\u00f6dinger, LLC, New York, NY, 2024. New York, NY. (2024)."},{"issue":"6","key":"57604_CR35","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1021\/ja00214a001","volume":"110","author":"WL Jorgensen","year":"1988","unstructured":"Jorgensen, W. L. & Tirado-Rives, J. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. J. Am. Chem. Soc. 110(6), 1657\u201366 (1988).","journal-title":"J. Am. Chem. Soc."},{"key":"57604_CR36","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","volume":"21","author":"JC Shelley","year":"2007","unstructured":"Shelley, J. C. et al. Epik: A software program for pK a prediction and protonation state generation for drug-like molecules. J. Comput. Aided Mol. Des. 21, 681\u201391 (2007).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"57604_CR37","doi-asserted-by":"crossref","unstructured":"Balasubramanian, B., Ahmad, S., Alok, V., Khan, F.N., Anand, K., Mehta, S. et al. Exosomes as an emerging nanoplatform for functional therapeutics. Handbook on nanobiomaterials for therapeutics and diagnostic applications. 483-98 (2021).","DOI":"10.1016\/B978-0-12-821013-0.00002-7"},{"key":"57604_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.compbiolchem.2018.02.008","volume":"73","author":"T Ban","year":"2018","unstructured":"Ban, T., Ohue, M. & Akiyama, Y. Multiple grid arrangement improves ligand docking with unknown binding sites: Application to the inverse docking problem. Comput. Biol. Chem. 73, 139\u201346 (2018).","journal-title":"Comput. Biol. Chem."},{"key":"57604_CR39","doi-asserted-by":"publisher","first-page":"110163","DOI":"10.1016\/j.compbiomed.2025.110163","volume":"191","author":"N Bano","year":"2025","unstructured":"Bano, N., Ahmad, S., Gupta, D. & Raza, K. FDA-approved Levophed as an alternative multitargeted therapeutic against cervical cancer transferase, cell cycle, and regulatory proteins. Comput. Biol. Med. 191, 110163 (2025).","journal-title":"Comput. Biol. Med."},{"key":"57604_CR40","doi-asserted-by":"publisher","first-page":"141703","DOI":"10.1016\/j.ijbiomac.2025.141703","volume":"306","author":"S Ahmad","year":"2025","unstructured":"Ahmad, S., Bano, N. & Raza, K. Evaluating the polypharmacological potency of FEDPN from ChEMBL BioAssays against lung cancer EGFR, ALK, TrkA and KRAS proteins. Int. J. Biol. Macromol. 306, 141703 (2025).","journal-title":"Int. J. Biol. Macromol."},{"key":"57604_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.53388\/MDM202508008","volume":"8","author":"S Ahmad","year":"2025","unstructured":"Ahmad, S., Bano, N. & Raza, K. RCSB protein data bank: Revolutionising drug discovery and design for over five decades. Med. Data Min. 8, 7\u201311 (2025).","journal-title":"Med. Data Min."},{"key":"57604_CR42","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/978-981-19-8249-1_13","volume-title":"Therapeutic protein-based vaccines","author":"S Ahmad","year":"2023","unstructured":"Ahmad, S. et al. Therapeutic protein-based vaccines 355\u201384 (Springer, 2023)."},{"key":"57604_CR43","unstructured":"Release, S. Schr\u00f6dinger Suite 2024 Protein Preparation Wizard. Epik, Schr\u00f6dinger, LLC, New York, NY. (2024)."},{"key":"57604_CR44","doi-asserted-by":"crossref","unstructured":"Jacobson, M.P., Pincus, D.L., Rapp, C.S., Day, T.J., Honig, B., Shaw, D.E. et al. A hierarchical approach to all\u2010atom protein loop prediction. Proteins: Structure, Function, and Bioinformatics. 55(2):351-67 (2004).","DOI":"10.1002\/prot.10613"},{"issue":"2","key":"57604_CR45","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1021\/ct100578z","volume":"7","author":"MH Olsson","year":"2011","unstructured":"Olsson, M. H., S\u00f8ndergaard, C. R., Rostkowski, M. & Jensen, J. H. PROPKA3: Consistent treatment of internal and surface residues in empirical p K a predictions. J. Chem. Theor. Comput. 7(2), 525\u201337 (2011).","journal-title":"J. Chem. Theor. Comput."},{"key":"57604_CR46","unstructured":"Release, S. Receptor grid generation. Schr\u00f6dinger, LLC, New York, NY. (2024)."},{"key":"57604_CR47","doi-asserted-by":"crossref","unstructured":"Yadav, M.K., Ahmad, S., Raza, K., Kumar, S., Eswaran, M., Pasha, K.M. M. Predictive modeling and therapeutic repurposing of natural compounds against the receptor-binding domain of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics. 1-13 (2022).","DOI":"10.1080\/07391102.2021.2021993"},{"key":"57604_CR48","first-page":"65","volume-title":"Application of machine learning\u2013based approaches in stem cell research","author":"MK Yadav","year":"2024","unstructured":"Yadav, M. K. et al. Application of machine learning\u2013based approaches in stem cell research 65\u201376 (Elsevier, 2024)."},{"key":"57604_CR49","unstructured":"Release, S. Glide: Schr\u00f6dinger. LLC, NY, USA. (2024)."},{"key":"57604_CR50","doi-asserted-by":"publisher","first-page":"135701","DOI":"10.1016\/j.molstruc.2023.135701","volume":"1287","author":"M Rana","year":"2023","unstructured":"Rana, M. et al. Synthesis, single crystal, TD-DFT, molecular dynamics simulation and DNA binding studies of carbothioamide analog. J. Mol. Struct. 1287, 135701 (2023).","journal-title":"J. Mol. Struct."},{"issue":"18","key":"57604_CR51","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/qua.24481","volume":"113","author":"AD Bochevarov","year":"2013","unstructured":"Bochevarov, A. D. et al. Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences. Int. J. Q. Chem. 113(18), 2110\u201342 (2013).","journal-title":"Int. J. Q. Chem."},{"key":"57604_CR52","unstructured":"Release, S. Jaguar, Schr\u00f6dinger, LLC, New York, NY 2024. (2024)."},{"key":"57604_CR53","unstructured":"Carb\u00f3, R., Riera, J. M. A general SCF theory: Springer Science & Business Media; (2012)."},{"issue":"10","key":"57604_CR54","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1063\/1.449880","volume":"84","author":"TP Hamilton","year":"1986","unstructured":"Hamilton, T. P. & Pulay, P. Direct inversion in the iterative subspace (DIIS) optimization of open-shell, excited-state, and small multiconfiguration SCF wave functions. J. Chem. Phys. 84(10), 5728\u201334 (1986).","journal-title":"J. Chem. Phys."},{"key":"57604_CR55","first-page":"731","volume-title":"Computer-aided prediction of pharmacokinetic (ADMET) properties","author":"B Chandrasekaran","year":"2018","unstructured":"Chandrasekaran, B., Abed, S. N., Al-Attraqchi, O., Kuche, K. & Tekade, R. K. Computer-aided prediction of pharmacokinetic (ADMET) properties 731\u201355 (Elsevier, 2018)."},{"key":"57604_CR56","unstructured":"QikProp, S. Schr\u00f6dinger Release 2024. Maestro LLC, New York, USA. (2024)."},{"issue":"9","key":"57604_CR57","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1021\/ja0771033","volume":"130","author":"R Abel","year":"2008","unstructured":"Abel, R., Young, T., Farid, R., Berne, B. J. & Friesner, R. A. Role of the active-site solvent in the thermodynamics of factor Xa ligand binding. J. Am. Chem. Soc. 130(9), 2817\u201331 (2008).","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"57604_CR58","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1073\/pnas.0610202104","volume":"104","author":"T Young","year":"2007","unstructured":"Young, T., Abel, R., Kim, B., Berne, B. J. & Friesner, R. A. Motifs for molecular recognition exploiting hydrophobic enclosure in protein\u2013ligand binding. Proc. Natl. Acad. Sci. 104(3), 808\u201313 (2007).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"57604_CR59","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/17460441.2023.2267015","volume":"19","author":"AA Kaczor","year":"2024","unstructured":"Kaczor, A. A., Zi\u0119ba, A. & Matosiuk, D. The application of WaterMap-guided structure-based virtual screening in novel drug discovery. Exp. Opin. Drug Discov. 19(1), 73\u201383 (2024).","journal-title":"Exp. Opin. Drug Discov."},{"key":"57604_CR60","doi-asserted-by":"crossref","unstructured":"Bowers, K.J., Chow, E., Xu, H., Dror, R.O., Eastwood, M.P., Gregersen, B.A., et al. editors. Scalable algorithms for molecular dynamics simulations on commodity clusters. Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing; (2006).","DOI":"10.1145\/1188455.1188544"},{"key":"57604_CR61","unstructured":"Release, S. Desmond molecular dynamics system, DE Shaw research, New York, NY, 2024. Maestro-Desmond Interoperability Tools, Schr\u00f6dinger, New York, NY. (2024)."},{"issue":"43","key":"57604_CR62","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark, P. & Nilsson, L. Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J. Phys. Chem. A. 105(43), 9954\u201360 (2001).","journal-title":"J. Phys. Chem. A."},{"issue":"1","key":"57604_CR63","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/00268977200100031","volume":"23","author":"I McDonald","year":"1972","unstructured":"McDonald, I. NpT-ensemble Monte Carlo calculations for binary liquid mixtures. Mol. Phys. 23(1), 41\u201358 (1972).","journal-title":"Mol. Phys."},{"key":"57604_CR64","doi-asserted-by":"crossref","unstructured":"Tripathi, M.K., Ahmad, S., Tyagi, R., Dahiya, V., Yadav, M.K. Fundamentals of molecular modeling in drug design. Computer Aided Drug Design (CADD): From ligand-based methods to structure-based approaches: Elsevier; p. 125-55 (2022).","DOI":"10.1016\/B978-0-323-90608-1.00001-0"},{"issue":"11","key":"57604_CR65","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1080\/17460441.2021.1942836","volume":"16","author":"T Tuccinardi","year":"2021","unstructured":"Tuccinardi, T. What is the current value of MM\/PBSA and MM\/GBSA methods in drug discovery?. Exp. Opin. Drug Discov. 16(11), 1233\u20137 (2021).","journal-title":"Exp. Opin. Drug Discov."},{"issue":"16","key":"57604_CR66","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang, E. et al. End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design. Chemical reviews. 119(16), 9478\u2013508 (2019).","journal-title":"Chemical reviews."},{"key":"57604_CR67","doi-asserted-by":"crossref","unstructured":"Hou, T., Wang, J., Zhang, W., Xu, X. ADME evaluation in drug discovery. 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules? Journal of Chemical Information and Modeling. 47(2):460-3 (2007).","DOI":"10.1021\/ci6003515"},{"key":"57604_CR68","unstructured":"Vandenberg, J. I., Perry, M. D., Perrin, M. J., Mann, S.A., Ke, Y., Hill, A.P. hERG K+ channels: structure, function, and clinical significance. Physiological reviews. (2012)."},{"issue":"2","key":"57604_CR69","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/wcms.19","volume":"1","author":"JS Murray","year":"2011","unstructured":"Murray, J. S. & Politzer, P. The electrostatic potential: an overview. Wiley Interdiscip. Rev. Comput. Mol. Sci. 1(2), 153\u201363 (2011).","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"issue":"22","key":"57604_CR70","doi-asserted-by":"publisher","first-page":"8440","DOI":"10.1073\/pnas.83.22.8440","volume":"83","author":"RG Pearson","year":"1986","unstructured":"Pearson, R. G. Absolute electronegativity and hardness correlated with molecular orbital theory. Proc. Natl Acad. Sci. 83(22), 8440\u20131 (1986).","journal-title":"Proc. Natl Acad. Sci."},{"issue":"5","key":"57604_CR71","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden, S. & Ryde, U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Exp. Opin. Drug Discov. 10(5), 449\u201361 (2015).","journal-title":"Exp. Opin. Drug Discov."},{"issue":"1","key":"57604_CR72","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom, S. et al. Drug repurposing: progress, challenges and recommendations. Nature Rev. Drug Discov. 18(1), 41\u201358 (2019).","journal-title":"Nature Rev. Drug Discov."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57604-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57604-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57604-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:02:58Z","timestamp":1788739378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57604-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57604"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57604-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethical obligations are not applicable as the study is computational.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent to submit the manuscript to this Journal.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27845"}}